GPRC5B and diabetes mellitus: We have also identified that several well-characterised GPCRs (CASR, GPRC5B, GPR119, F2RL1), which are either current drug targets or under evaluation as potential diabetes therapeutic targets, are highly expressed in both human and mouse islets.